NeuroScientific Biopharmaceuticals has delivered another promising set of patient outcomes from its StemSmart stem cell therapy, reporting that four of the five patients treated for fistulising Crohn’s disease under its Special Access Program demonstrated a clinical response.All five patients showed improvement following treatment, with no…
Shake intensity Pop. density Note: Map shows the area with a shake intensity of 3 or greater, which U.S.G.S. defines…
The City of Vancouver has released its Human Rights Framework ahead of the FIFA World Cup, which starts on Saturday,…
A major new operation in underway as police search for Gus Lamont, the missing four-year-old last seen in September, 2025.On…
The Liberal prime minister called for an independent investigation into Israeli mistreatment, but stopped short of penalties.Published On 26 May…
Business
Global oil prices fell on the day, with West Texas Intermediate approaching the psychologically important $90-a-barrel level and Brent crude easing towards the mid-$90s…
Author Ahmed Barakat Author Ahmed Barakat Part of the Team Since Aug…
U.S. Federal Reserve Chair Jerome Powell attends a press conference in Washington,…
Intel stock NASDAQ:INTC have surged 225% in 2026, marking a sharp turnaround…
Politics
NEWYou can now listen to Fox News articles! As Maine’s presumptive Democratic nominee for Senate faces criticism for insulting the…
Tech & Innovation
Consumers with the Tesla Model Y L electric vehicle in Tesla stores in Shanghai, China on October 19, 2025. CFOTO | Future Publishing | Getty ImagesAfter…